Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Reexamination Certificate
2007-08-13
2010-06-29
Yaen, Christopher H (Department: 1643)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Reexamination Certificate
active
07744891
ABSTRACT:
Compositions and methods comprising “lymphotoxin-β receptor blocking agents” which block lymphotoxin-β receptor signaling and are useful for altering immunological diseases, and particularly antibody mediated immune responses.
REFERENCES:
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5661004 (1997-08-01), Browning et al.
patent: 5670149 (1997-09-01), Browning et al.
patent: 5795964 (1998-08-01), Browning et al.
patent: 5925351 (1999-07-01), Browning et al.
patent: 6312691 (2001-11-01), Browning et al.
patent: 6403087 (2002-06-01), Browning et al.
patent: 6669941 (2003-12-01), Browning et al.
patent: 7001598 (2006-02-01), Browning et al.
patent: 7030080 (2006-04-01), Browning et al.
patent: 7060667 (2006-06-01), Browning et al.
patent: 7255854 (2007-08-01), Browning et al.
patent: 2002/0197254 (2002-12-01), Browning et al.
patent: 2005/0037003 (2005-02-01), Browning et al.
patent: 2005/0281811 (2005-12-01), Browning et al.
patent: 2006/0280722 (2006-12-01), Browning et al.
patent: 2007/0116668 (2007-05-01), Browning et al.
patent: 0840616 (2004-10-01), None
patent: WO-92/00329 (1992-01-01), None
patent: WO-94/13808 (1994-06-01), None
patent: WO-97/03687 (1997-02-01), None
patent: WO-97/20063 (1997-06-01), None
Alimzhanov, Marat B. et al., “Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice,”Proc. Natl. Acad. Sci. USA, vol. 94:9302-9307 (1997).
Androlewicz, Matthew J. et al., “Lymphotoxin Is Expressed as a Heteromeric Complex with a Distinct 33-kDa Glycoprotein on the Surface of an Activated Human T Cell Hybridoma,”The Journal of Biological Chemistry, vol. 267(4):2542-2547 (1992).
Arulanandam, Antonio R.N. et al., “A Soluble Multimeric Recombinant CD2 Protein Identifies CD48 as a Low Affinity Ligand for Human CD2: Divergence of CD2 Ligands during the Evolution of Humans and Mice,”J. Exp. Med., vol. 177:1439-1450 (1993).
Banks, Theresa A. et al., “Lymphotoxin-α-Deficient Mice, Effects on Secondary Lymphoid Organ Development and Humoral Immune Responsiveness,”The Journal of Immunology, vol. 155:1685-1693 (1995).
Barnetson, Ross, “Hypersensitivity—Type IV,”Essential Immunology, Ivan Roitt, Editor, Chapter 22, pp. 22.1-22.12 (1993).
Bowie, James U. et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science, vol. 247:1306-1310 (1990).
Briskin, Michael J. et al., “MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1,”Nature, vol. 363:461-464 (1993).
Browning, Jeffrey L. et al., “Characterization of Surface Symphotoxin Forms, Use of Specific Monoclonal Antibodies and Soluble Receptors,”The Journal of Immunology, vol. 154:33-46 (1995).
Browning, Jeffrey L. et al., “Lymphotoxin and an Associated 33-kDa Glycoprotein are Expressed on the Surface of an Activated Human T Cell Hybridoma,”The Journal of Immunology, vol. 147:1230-1237 (1991).
Browning, Jeffrey L. et al., “Lymphotoxin β, a Novel Member of the TNF Family That Forms a Heteromeric Complex with Lymphotoxin on the Cell Surface,”Cell, vol. 72:847-856 (1993).
Browning, Jeffrey L. et al., “Signaling through the Lymphotoxin β Receptor Induces the Death of Some Adenocarcinoma Tumor Lines,”J. Exp. Med., vol. 183:867-878 (1996).
Burgess, Wilson H. et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue,”The Journal of Cell Biology, vol. 111:2129-2138 (1990).
Cavert, Winston et al., “Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection,”Science, vol. 276:960-964 (1997).
Chen, Chyi-Ying A. et al., “AU-rich elements: characterization and importance in mRNA degradation,”TIBS, vol. 20:465-470 (1995).
Crowe, Paul D. et al., “A Lymphotoxin-β-Specific Receptor,”Science, vol. 264:707-710 (1994).
De Togni, Pietro et al., “Abnormal Development of Peripheral Lymphoid Organ in Mice Deficient in Lymphotoxin,”Science, vol. 264:703-707 (1994).
Dijkstra, Christine D. et al., “Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities,”Immunology, vol. 55:23-30 (1985).
Düzgünes, Nejat et al., “Liposome Targeting to HIV-Infected Cells Via Recombinant Soluble CD4 and CD4-IgG (Immunoadhesin),”Journal of Cellular Biochemistry, Poster Selection Q514, p. 77 (1992).
Endres, Robert et al., “Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin βand Tumor Necrosis Factor by B Cells,”J. Exp. Med., vol. 189(1):159-167 (1999).
Eppstein, Deborah A. et al., “Biological activity of liposome-encapsulated murine interferon γ is mediated by a cell membrane receptor,”Proc. Natl. Acad. Sci. USA, vol. 82:3688-3692 (1985).
Erickson, Sharon L. et al., “Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice,”Nature, vol. 372:560-563 (1994).
Ettinger, Rachel et al., “Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgG1 fusion protein,”Proc. Natl. Acad. Sci. USA, vol. 93:13102-13107 (1996).
Fitch, F.W. et al., “Differential Regulation of Murine T Lymphocyte Subsets,”Annu. Rev. Immunol., vol. 11:29-48 (1993).
Force, Walker R. et al., “Mouse Lymphotoxin-β Receptor,”The Journal of Immunology, vol. 155:5280-5288 (1995).
Foy, Teresa M. et al., “gp39-CD40 Interactions Are Essential for Germinal Center Formation and the Development of B Cell Memory,”J. Exp. Med., vol. 180:157-163 (1994).
Fu, Yang-Xin et al., “B Lymphocytes Induce the Formation of Follicular Dendritic Cell Clusters in a Lymphotoxin α-dependent Fashion,” J. Exp. Med., vol. 187(7):1009-1018 (1998).
Fu, Yang-Xin et al., “Development and Maturation of Secondary Lymphoid Tissues,”Annu. Rev. Immunol., vol. 17:399-433 (1999).
Fu, Yang-Xin et al., “Lymphotoxin-α (LTα) Supports Development of Splenic Follicular Structure That Is Required for IgG Responses,”J. Exp. Med., vol. 185(12):2111-2120 (1997).
Fötterer, Agnes et al., “The Lymphotoxin β Receptor Controls Organogenesis and Affinity Maturation in Peripheral Lymphoid Tissues,”Immunity, vol. 9:59-70 (1998).
Gommerman, Jennifer L. et al., “Lymphotoxin/Light, Lymphoid Microenvironments and Autoimmune Disease,”Nature, vol. 3:642-655 (2003).
Gonzalez, Mercedes et al., “The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles,”J. Exp. Med., vol. 187(7):997-1007 (1998).
Goodwin, Raymond G. et al., “Molecular and Biological Characterization of a Ligand for CD27 Defines a New Family of Cytokines with Homology to Tumor Necrosis Factor,”Cell, vol. 73:447-456 (1993).
Györfy, Zs. et al., “Alteration of the TNF Sensitivity and Membrane Viscosity of Target Cells,”European Cytokine Network, vol. 7(2):167, No. 16 (1996).
Han, Shuhua et al., “Cellular Interaction in Germinal Centers, Roles of CD40 Ligand and B7-2 in Established Germinal Centers,”The Journal of Immunology, vol. 155:556-567 (1995).
Heath, Sonya et al., “Follicular dendritic cells and human immunodeficiendcy virus infectivity,”Nature, vol. 377:740-744 (1995).
Hwang, Karl J. et al., “Hepatic uptake and degradation of unilamellar sphingomyelin/cholester
Browning Jeffrey L.
Hochman Paula S.
Mackay Fabienne
Rennert Paul D.
Biogen Idec MA Inc.
Lahive & Cockfield LLP
Williams Megan E.
Yaen Christopher H
LandOfFree
Soluble lymphotoxin-beta receptors and anti-lymphotoxin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble lymphotoxin-beta receptors and anti-lymphotoxin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble lymphotoxin-beta receptors and anti-lymphotoxin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245335